Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation

ACS Chemical Biology

Volumn 8, Issue 7, 2013, Pages 1497-1506

  Ortuso, Francesco ^a   Paduano, Francesco ^a   Carotenuto, Alfonso ^b   Gomez Monterrey, Isabel ^b   Bilotta, Anna ^a   Gaudio, Eugenio ^a,c   Sala, Marina ^b   Artese, Anna ^a   Vernieri, Ermelinda ^d   Dattilo, Vincenzo ^a   Iuliano, Rodolfo ^a   Brancaccio, Diego ^b   Bertamino, Alessia ^d   Musella, Simona ^d   Alcaro, Stefano ^a   Grieco, Paolo ^b   Perrotti, Nicola ^a   Croce, Carlo M ^c   Novellino, Ettore ^b   Fusco, Alfredo ^b   Campiglia, Pietro ^b,d   Trapasso, Francesco ^a   more..

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTINEOPLASTIC AGENT; NONAPEPTIDE; PTPRJ AGONIST PEPTIDE 19; PTPRJ AGONIST PEPTIDE 19.1; PTPRJ AGONIST PEPTIDE 19.2; PTPRJ AGONIST PEPTIDE 19.3; PTPRJ AGONIST PEPTIDE 19.4; PTPRJ AGONIST PEPTIDE 19.5; PTPRJ AGONIST PEPTIDE 19.6; PTPRJ AGONIST PEPTIDE 19.7; PTPRJ AGONIST PEPTIDE 19.8; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CELL; CANCER CELL; CANCER CELL PROLIFERATION; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG SYNTHESIS; ENDOTHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR MODEL; NEOPLASM; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE; CELL PROLIFERATION; FEMALE; HELA CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MONTE CARLO METHOD; OLIGOPEPTIDES; PEPTIDES; PROTEIN FOLDING; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3;

EID: 84880544411     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb3007192     Document Type: Article

References (49)

1. Blume-Jensen, P. and Hunter, T. (2001) Oncogenic kinase signalling Nature 411, 355-365
2. Sawyers, C. (2004) Targeted cancer therapy Nature 432, 294-297
3. Zhang, J., Yang, P. L., and Gray, N. S. (2009) Targeting cancer with small molecule kinase inhibitors Nat. Rev. Cancer 9, 28-39
4. Easty, D., Gallagher, W., and Bennett, D. C. (2006) Protein tyrosine phosphatases, new targets for cancer therapy Curr. Cancer Drug Targets 6, 519-532
5. Honda, H., Inazawa, J., Nishida, J., Yazaki, Y., and Hirai, H. (1994) Molecular cloning, characterization, and chromosomal localization of a novel protein-tyrosine phosphatase, HPTPeta Blood 84, 4186-4194
6. Ostman, A., Yang, Q., and Tonks, N. K. (1994) Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density Proc. Natl. Acad. Sci. U.S.A. 91, 9680-9684
7. Ostman, A., Hellberg, C., and Bohmer, F. D. (2006) Protein-tyrosine phosphatases and cancer Nat. Rev. Cancer 6, 307-320
8. Trapasso, F., Drusco, A., Costinean, S., Alder, H., Aqeilan, R. I., Iuliano, R., Gaudio, E., Raso, C., Zanesi, N., Croce, C. M., and Fusco, A. (2006) Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis DNA Cell Biol. 25, 376-382
9. Iuliano, R., Le Pera, I., Cristofaro, C., Baudi, F., Arturi, F., Pallante, P., Martelli, M. L., Trapasso, F., Chiariotti, L., and Fusco, A. (2004) The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis Oncogene 23, 8432-8438
10. Zhang, L., Martelli, M. L., Battaglia, C., Trapasso, F., Tramontano, D., Viglietto, G., Porcellini, A., Santoro, M., and Fusco, A. (1997) Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase Exp. Cell Res. 235, 62-70
11. Trapasso, F., Iuliano, R., Boccia, A., Stella, A., Visconti, R., Bruni, P., Baldassarre, G., Santoro, M., Viglietto, G., and Fusco, A. (2000) Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1) Mol. Cell. Biol. 20, 9236-9246
12. Ruivenkamp, C. A., van Wezel, T., Zanon, C., Stassen, A. P., Vlcek, C., Csikós, T., Klous, A. M., Tripodis, N., Perrakis, A., Boerrigter, L., Groot, P. C., Lindeman, J., Mooi, W. J., Meijjer, G. A., Scholten, G., Dauwerse, H., Paces, V., van Zandwijk, N., van Ommen, G. J., and Demant, P. (2002) Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers Nat. Genet. 31, 295-300
13. Ruivenkamp, C., Hermsen, M., Postma, C., Klous, A., Baak, J., Meijer, G., and Demant, P. (2003) LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21 Oncogene 22, 3472-3474
14. Iuliano, R., Trapasso, F., Le Pera, I., Schepis, F., Samà, I., Clodomiro, A., Dumon, K. R., Santoro, M., Chiariotti, L., Viglietto, G., and Fusco, A. (2003) An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo Cancer Res. 63, 882-886
15. Trapasso, F., Yendamuri, S., Dumon, K. R., Iuliano, R., Cesari, R., Feig, B., Seto, R., Infante, L., Ishii, H., Vecchione, A., During, M. J., Croce, C. M., and Fusco, A. (2004) Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo Carcinogenesis 25, 2107-2114
16. Kovalenko, M., Denner, K., Sandström, J., Persson, C., Gross, S., Jandt, E., Vilella, R., Böhmer, F., and Ostman, A. (2000) Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1 J. Biol. Chem. 275, 16219-16226
17. Palka, H. L., Park, M., and Tonks, N. K. (2003) Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1 J. Biol. Chem. 278, 5728-5735
18. Iervolino, A., Iuliano, R., Trapasso, F., Viglietto, G., Melillo, R. M., Carlomagno, F., Santoro, M., and Fusco, A. (2006) The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins Cancer Res. 66, 6280-6287
19. Berset, T. A., Hoier, E. F., and Hajnal, A. (2005) The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions Genes Dev. 19, 1328-1340
20. Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation Cell 144, 646-674
21. Lampugnani, M. G., Zanetti, A., Corada, M., Takahashi, T., Balconi, G., Breviario, F., Orsenigo, F., Cattelino, A., Kemler, R., Daniel, T. O., and Dejana, E. (2003) Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148 J. Cell. Biol. 161, 793-804
22. Takahashi, T., Takahashi, K., Mernaugh, R. L., Tsuboi, N., Liu, H., and Daniel, T. O. (2006) A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis Blood 108, 1234-1242
23. Paduano, F., Ortuso, F., Campiglia, P., Raso, C., Iaccino, E., Gaspari, M., Gaudio, E., Mangone, G., Carotenuto, A., Bilotta, A., Narciso, D., Palmieri, C., Agosti, V., Artese, A., Gomez-Monterrey, I., Sala, M., Cuda, G., Iuliano, R., Perrotti, N., Scala, G., Viglietto, G., Alcaro, S., Croce, C. M., Novellino, E., Fusco, A., and Trapasso, F. (2012) Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity ACS Chem. Biol. 7, 1666-1676
24. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids; John Wiley & Sons, Inc., New York.
25. Mayer, M. and Meyer, B. (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy Angew. Chem., Int. Ed. 38, 1784-1788
26. De Munter, S., Köhn, M., and Bollen, M. (2013) Challenges and opportunities in the development of protein phosphatase-directed therapeutics ACS Chem. Biol. 8, 36-45
27. Sacco, F., Tinti, M., Palma, A., Ferrari, E., Nardozza, A. P., Hooft van Huijsduijnen, R., Takahashi, T., Castagnoli, L., and Cesareni, G. (2009) Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases J. Biol. Chem. 284, 22048-22058
28. Sorby, M., Sandstrom, J., and Ostman, A. (2001) An extracellular ligand increases the specific activity of the receptor-like protein tyrosine phosphatase DEP-1 Oncogene 20 (37) 5219-5224
29. Whiteford, J. R., Xian, X., Chaussade, C., Vanhaesebroeck, B., Nourshargh, S., and Couchman, J. R. (2011) Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148 Mol. Biol. Cell 22, 3609-3624
30. Takahashi, K., Mernaugh, R. L., Friedman, D. B., Weller, R., Tsuboi, N., Yamashita, H., Quaranta, V., and Takahashi, T. (2012) Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase Proc. Natl. Acad. Sci. U.S.A. 109, 1985-1990
31. Bouck, N., Stellmach, V., and Hsu, S. C. (1996) How tumors become angiogenic Adv. Cancer Res. 69, 135-174
32. Brunner, P. M., Heier, P. C., Mihaly-Bison, J., Priglinger, U., Binder, B. R., and Prager, G. W. (2011) Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cells Blood 117, 4154-4161
33. Spring, K., Chabot, C., Langlois, S., Lapointe, L., Trinh, N. T., Caron, C., Hebda, J. K., Gavard, J., Elchebly, M., and Royal, I. (2012) Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation Blood 120, 2745-2756
34. Iuliano, R., Raso, C., Quintiero, A., Le Pera, I., Pichiorri, F., Palumbo, T., Palmieri, D., Pattarozzi, A., Florio, T., Viglietto, G., Trapasso, F., Croce, C. M., and Fusco, A. (2009) The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization J. Biochem. 145, 377-385
35. Atherton, E. and Sheppard, R. C. (1989) Solid-Phase Peptide Synthesis: A Practical Approach; IRL Press: Oxford, U.K.
36. Miranda, L. P. and Alewood, P. F. (1999) Accelerated chemical synthesis of peptides and small proteins Proc. Natl. Acad. Sci. U.S.A. 96, 1181-1186
37. Paduano, F., Dattilo, V., Narciso, D., Bilotta, A., Gaudio, E., Menniti, M., Agosti, V., Palmieri, C., Perrotti, N., Fusco, A., Trapasso, F., and Iuliano, R. (2013) Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328 FEBS J. 280, 401-412
38. Hwang, T. L. and Shaka, A. J. (1995) Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients J. Magn. Reson. 112, 275-279
39. Braunschweiler, L. and Ernst, R. R. (1983) Coherence transfer by isotropic mixing: application to proton correlation spectroscopy J. Magn. Reson. 53, 521-528
40. Jenner, J., Meyer, B. H., Bachman, P., and Ernst, R. R. (1979) Investigation of exchange processes by two-dimensional NMR spectroscopy J. Chem. Phys. 71, 4546-4553
41. States, D. J., Haberkorn, R. A., and Ruben, D. J. (1982) A two-dimensional nuclear Overhauser experiment with pure absorption phase four quadrants J. Magn. Reson. 48, 286-292
42. Bartels, C., Xia, T. H., Billeter, M., Guntert, P., and Wuthrich, K. (1995) The program XEASY for computer-supported NMR spectral analysis of biological macromolecules J. Biomol. NMR 6, 1-10
43. Schrödinger LLC, New York, NY., 2010; http://www.schrodinger.com
44. Mohamadi, F., Richard, N. G. J., Guida, W. C., Liskamp, R., Lipton, M., Caufield, C., Chang, G., Hendrickson, T., and Still, W. C. (1990) MacroModel-an integrated software system for modeling organic and bioorganic molecules using molecular mechanics J. Comput. Chem. 11, 440-467
45. McDonald, D. Q. and Still, W. C. (1992) AMBER* Torsional Parameters for the Peptide Backbone Tetrahedron Lett. 33, 7743-7746
46. Still, W. C., Tempczyk, A., Hawley, R. C., and Hendrickson, T. (1990) Semianalytical treatment of solvation for molecular mechanics and dynamics J. Am. Chem. Soc. 112, 6127-6129
47. Daura, X., Gademann, K., Jaun, B., Seebach, D., Van Gunsteren, W. F., and Mark, A. E. (1999) Peptide folding: When simulation meets experiment Angew. Chem., Int. Ed. 38, 236-240
48. Alcaro, S., Gasparrini, F., Incani, O., Mecucci, S., Misiti, D., and Pierini, M. (2000) A "quasi-flexible" automatic docking processing for studying stereoselective recognition mechanisms. Part I. Protocol validation J. Comput. Chem. 21, 515-530
49. 1H-NMR NOE correlation J. Comput. Chem. 28, 1119-1128